WO2007111847A3 - Use of additives for the reduction of non-specific binding in assays - Google Patents

Use of additives for the reduction of non-specific binding in assays Download PDF

Info

Publication number
WO2007111847A3
WO2007111847A3 PCT/US2007/006619 US2007006619W WO2007111847A3 WO 2007111847 A3 WO2007111847 A3 WO 2007111847A3 US 2007006619 W US2007006619 W US 2007006619W WO 2007111847 A3 WO2007111847 A3 WO 2007111847A3
Authority
WO
WIPO (PCT)
Prior art keywords
specific binding
assays
additives
reduction
reaction mixture
Prior art date
Application number
PCT/US2007/006619
Other languages
French (fr)
Other versions
WO2007111847A2 (en
Inventor
Stuart Levison
Paul Nix
Derek Levison
Original Assignee
Aokin Ag
Stuart Levison
Paul Nix
Derek Levison
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aokin Ag, Stuart Levison, Paul Nix, Derek Levison filed Critical Aokin Ag
Priority to EP07753260A priority Critical patent/EP2005169A2/en
Priority to US12/294,293 priority patent/US8124359B2/en
Publication of WO2007111847A2 publication Critical patent/WO2007111847A2/en
Publication of WO2007111847A3 publication Critical patent/WO2007111847A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding

Abstract

A method for reducing non-specific binding in an assay is provided herein. The method includes (a) providing a reaction mixture, which includes or is suspected to include a first component and a second component capable of binding to each other in a specific binding reaction, and (b) adding non-physiological amounts of at least one additive to the reaction mixture before, during or after binding in a sufficient amount to reduce non-specific binding in the reaction mixture. The method further includes (c) monitoring or measuring the presence and/or concentration of at least one of the first and second components after step (b).
PCT/US2007/006619 2006-03-24 2007-03-16 Use of additives for the reduction of non-specific binding in assays WO2007111847A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP07753260A EP2005169A2 (en) 2006-03-24 2007-03-16 Use of additives for the reduction of non-specific binding in assays
US12/294,293 US8124359B2 (en) 2006-03-24 2007-03-16 Use of additives for the reduction of non-specific binding in assays

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78561206P 2006-03-24 2006-03-24
US60/785,612 2006-03-24

Publications (2)

Publication Number Publication Date
WO2007111847A2 WO2007111847A2 (en) 2007-10-04
WO2007111847A3 true WO2007111847A3 (en) 2007-11-22

Family

ID=38226438

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/006619 WO2007111847A2 (en) 2006-03-24 2007-03-16 Use of additives for the reduction of non-specific binding in assays

Country Status (3)

Country Link
US (1) US8124359B2 (en)
EP (1) EP2005169A2 (en)
WO (1) WO2007111847A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7745153B2 (en) * 2008-02-06 2010-06-29 Pierce Biotechnology, Inc. Pyrocatechol violet-metal protein assay
DE102009010563A1 (en) 2009-02-16 2010-08-26 Matthias W. Engel Device for the detection of analytes in body fluids
US8486717B2 (en) 2011-01-18 2013-07-16 Symbolics, Llc Lateral flow assays using two dimensional features
US8956816B2 (en) 2012-06-05 2015-02-17 Pacific Biosciences Of California, Inc. Methods and compositions for performing analytical operations
US9874556B2 (en) 2012-07-18 2018-01-23 Symbolics, Llc Lateral flow assays using two dimensional features
DE102012107651A1 (en) 2012-08-21 2014-02-27 Astrium Gmbh Method for carrying out a biochemical analysis, in particular in space
US20140072959A1 (en) 2012-09-12 2014-03-13 Force Diagnostics, Inc. Rapid tests for insurance underwriting
US10408828B2 (en) 2013-02-26 2019-09-10 Astute Medical, Inc. Lateral flow assay with test strip retainer
WO2015038978A1 (en) 2013-09-13 2015-03-19 Symbolics, Llc Lateral flow assays using two dimensional test and control signal readout patterns
JP6559135B2 (en) * 2013-12-13 2019-08-14 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドＳｉｅｍｅｎｓ Ｈｅａｌｔｈｃａｒｅ Ｄｉａｇｎｏｓｔｉｃｓ Ｉｎｃ． Pretreatment agent in non-agglutination assay
CA2981297A1 (en) 2015-04-06 2016-10-13 Bludiagnostics, Inc. A test device for detecting an analyte in a saliva sample and method of use
US20210278403A1 (en) 2016-08-23 2021-09-09 Qoolabs, Inc. Lateral flow assay for assessing recombinant protein expression or reporter gene expression
JP2019158791A (en) * 2018-03-16 2019-09-19 ウシオ電機株式会社 Immunochromatography assay method, diluent for immunochromatography, and immunochromatography test kit
CN110850078B (en) * 2019-11-14 2023-04-07 苏州和迈精密仪器有限公司 Detection method based on double-antibody sandwich double-waveband fluorescence immunity

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155104A2 (en) * 1984-02-24 1985-09-18 AMERSHAM INTERNATIONAL plc Free analyte assay
EP0163393A2 (en) * 1984-04-05 1985-12-04 Seragen Diagnostics, Inc. A method of performing an agglutination immunoassay
EP0392332A2 (en) * 1989-04-12 1990-10-17 F. Hoffmann-La Roche Ag Fluorescence polarisation immunoassay and reagents for same
EP0535239A1 (en) * 1991-03-18 1993-04-07 Shiseido Company Limited Collagen assaying method and kit

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155104A2 (en) * 1984-02-24 1985-09-18 AMERSHAM INTERNATIONAL plc Free analyte assay
EP0163393A2 (en) * 1984-04-05 1985-12-04 Seragen Diagnostics, Inc. A method of performing an agglutination immunoassay
EP0392332A2 (en) * 1989-04-12 1990-10-17 F. Hoffmann-La Roche Ag Fluorescence polarisation immunoassay and reagents for same
EP0535239A1 (en) * 1991-03-18 1993-04-07 Shiseido Company Limited Collagen assaying method and kit

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AOKIN: "fluorescence polarisation to quantify contamination by zearalenone (ZON)", INTERNET ARTICLE, 29 September 2006 (2006-09-29), XP002442558, Retrieved from the Internet <URL:mycoglobe.ispa.cnr.it/download.php?sezione=results&id=28> [retrieved on 20070713] *
DANDLIKER W B ET AL: "INVESTIGATION OF ANTIGEN ANTIBODY KINETICS BY FLUORESCENCE POLARIZATION", IMMUNOCHEMISTRY, vol. 5, no. 2, 1968, pages 171 - 183, XP002442557, ISSN: 0019-2791 *
LEVISON S A ET AL: "Fluorescence polarization and intensity kinetic studies of antifluorescein antibody obtained at different stages of the immune response.", BIOCHEMISTRY 26 AUG 1975, vol. 14, no. 17, 26 August 1975 (1975-08-26), pages 3778 - 3786, XP002442556, ISSN: 0006-2960 *

Also Published As

Publication number Publication date
US20090311724A1 (en) 2009-12-17
EP2005169A2 (en) 2008-12-24
US8124359B2 (en) 2012-02-28
WO2007111847A2 (en) 2007-10-04

Similar Documents

Publication Publication Date Title
WO2007111847A3 (en) Use of additives for the reduction of non-specific binding in assays
WO2008005469A3 (en) Igfbp2 biomarker
WO2005073722A3 (en) Luminogenic and nonluminogenic multiplex assay
MY146468A (en) Devices and methods for detecting cells and other analytes
WO2008105896A3 (en) Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label
DK1931999T3 (en) Release agent for vitamin D compounds
GB201101621D0 (en) Method and product
CA2474175A1 (en) Automatic analyzer
HK1119244A1 (en) Detecting and predicting pre-eclampsia
WO2007113590A3 (en) Fluorescent assay
WO2008060394A3 (en) Methods and assays for detecting gp73-specific autoantibodies
WO2005010491A3 (en) Method for resupplying reagents in an automatic clinical analyzer
WO2009025364A1 (en) Non-specific reaction inhibitor
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
DE602007012836D1 (en) CD86 AND CD80 RECEPTOR CONCRETE TESTS
WO2006031986A3 (en) Methods and compositions for diagnosing neoplastic disease
ATE545025T1 (en) COMPOSITION, APPARATUS AND CORRESPONDING METHOD
ATE519116T1 (en) METHOD FOR NORMALIZING THE CONCENTRATION OF ANALYTES IN A URINE SAMPLE
WO2006046979A3 (en) Feline infectious peritonitis (fip) and systemic multi-organ coronavirus biomarkers and screening methods
EP1669853A3 (en) Enabling inter-subsystem resource sharing
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
WO2005121366A8 (en) Gene marker and utilization of the same
WO2009078151A1 (en) Method for measurement of high-molecular-weight adiponectin
WO2009126889A8 (en) Assays for detecting pregnancy-associated glycoproteins
TW200600807A (en) Single chip test method, component and its test system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07753260

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007753260

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12294293

Country of ref document: US